BLACK WEEKSLiekovky −15 % · kity −10 % · ostatné −5 %s kódomDoprava po Nemecku zadarmo od 200 €

Táto stránka bola preložená automaticky a môže obsahovať chyby. Ste rodený hovoriaci? Radi privítame vašu spätnú väzbu a opravy.Poslať spätnú väzbu

The Peptide Desk The Peptide Desk
ARA-290, fotografia produktu
Healing

ARA-290

Healing

  • Odosielame z Nemecka

Objednávka

Cena za kus - Doprava po Nemecku zadarmo od 200 € počas Black Weeks
  • DHL so sledovaním zásielky
  • Diskrétne balenie

4.6 z 5 na Trustpilote73 hodnotení

V skratke

ARA-290 v číslach

Kľúčové údaje z nášho lexikónu.

Celé heslo v lexikóne
Class
EPO-derived peptidenon-hematopoietic
Half-life
short
Use
Subcutaneousin mg
Sizes
10 to 16 mg2 sizes in the shop

Znalosti

Všetko o ARA-290

Hodí sa priobjednať

Čo k tomu potrebujete

Bakteriostatická voda sa do košíka pridá automaticky. Striekačky a tampóny jedným kliknutím.

Inzulínové striekačky

10 ks · 5.50 €

Alkoholové tampóny

50 ks · 10 €

Koľko vody?

Jednotky na striekačke pre vašu veľkosť liekovky.

Otvoriť kalkulačku →

FAQ

Časté otázky

Zdroje ku každej odpovedi: heslo v lexikóne

Máte ešte otázku?

Napíšte nám, náš tím vám pomôže.

What is ARA-290?

A small peptide with the drug name cibinetide, designed from the structure of erythropoietin. Unlike EPO it is meant not to make the body form red blood cells. It acts through the innate repair receptor, a complex of the EPO receptor and CD131.

What do the sarcoidosis studies show?

In the first pilot study with 22 participants the symptom score fell by 11.5 points after 4 weeks versus 2.9 with placebo. A second study with daily dosing under the skin for 28 days found fewer symptoms, more nerve fibres in the cornea and a longer walking distance. In the phase 2b trial with 64 participants only the middle study dose was significant.

What about type 2 diabetes?

In a phase 2 trial with daily dosing under the skin for 28 days long-term blood sugar and blood lipids improved over 56 days and so did nerve pain symptoms. In participants with clearly reduced corneal nerve fibre density this density increased, with placebo it did not.

Does ARA-290 help with eye diseases?

In diabetic macular oedema a small study with 9 participants showed no improvement in visual acuity or retinal thickness after 12 weeks. Only the visual function questionnaire came out slightly better. The trial ended early because the study drug expired.

Does ARA-290 affect mood?

In a study with 36 healthy people the brain responded more weakly to happy faces one week after dosing and attention to positive pictures increased. ARA-290 had no effect on mood or emotional state. A clear antidepressant-like profile did not emerge.

Which side effects are known?

No safety concerns appeared in the studies. In diabetic macular oedema there were no serious side effects and no antibodies against the compound after 12 weeks. The abstracts give no percentages for individual side effects.

Súvisiace

Súvisiace produkty